RadNet, Inc.
corporate_fare Company Profile
RadNet, Inc. (NASDAQ:RDNT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 19 items for RDNT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 8/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for RDNT spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- RadNet Q2 Revenue Surges 25% to $622.7M; Digital Health ARR Doubles to $105.5M
- RadNet Q2 Revenue Jumps 25% to Record $622.7M, Lifts 2026 Guidance
- FDA Clears DeepHealth's AI Breast Suite for Cardiovascular Insights, Enhanced Cancer Detection
- RadNet Secures $250M Incremental Term Loan, Reduces Interest Rates on Credit Facilities
- RadNet Secures $250M Incremental Term Loan, Exceeding Prior Target
Financial Snapshot
Short Interest & Short Volume
11.93 days to coverFINRA reported short interest of 9,671,100 shares in RDNT as of the September 15, 2026 settlement, a 2.7% decrease from the prior period — about 11.9 days to cover at its recent average daily volume. On October 2, 2026, 86.2% of RDNT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for RDNT, detected from its recent SEC filings · based on capital-structure filings through 2026-08-14.
Resale Registration · No Proceeds to Company
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →